ARCHIVES

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Bush Budget Stresses Research Now, Public Health Interventions Later.

April 13, 2001

No Controversy Over Cancer Act This Time

May 25, 1990

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

May 21, 1999

NCI Has No Intention Of “Dismembering” Groups, Official Says

June 12, 1998

Certification Means More Money for Nurses, ONS Finds

June 29, 1990

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003